DNA Shareholders' Nomination Committee's proposal concerning members and remuneration of the Board of Directors

DNA PLC STOCK EXCHANGE RELEASE 1 MARCH 2017 AT 8:30 AM EET DNA Shareholders' Nomination Committee's proposal for the Annual General Meeting 2017 The Shareholders' Nomination Committee has submitted a proposal concerning Board members and their remuneration. Number of members on the Board of...
Comunicato Precedente

next
Comunicato Successivo

next
London, (informazione.it - comunicati stampa - telecomunicazioni)

DNA PLC STOCK EXCHANGE RELEASE 1 MARCH 2017 AT 8:30 AM EET

DNA Shareholders' Nomination Committee's proposal for the Annual General Meeting 2017

The Shareholders' Nomination Committee has submitted a proposal concerning Board members and their remuneration.

Number of members on the Board of Directors

The Shareholders' Nomination Committee proposes to the Annual General Meeting of DNA Plc, to be held on 22 March 2017, that the Board of Directors has seven members. The term of office of the Board of Directors will continue until the end of the following Annual General Meeting.

Composition of the Board of Directors

The Shareholders' Nomination Committee proposes to the Annual General Meeting that, among current members of the Board Pertti Korhonen, Kirsi Sormunen, Anu Nissinen, Tero Ojanperä, Margus Schults and Jukka Ottela be reselected and Heikki Mäkijärvi be appointed as a new member of the Board of Directors. Current member Jarmo Leino has announced that he is unavailable as Board member. Each person proposed for nomination has given his or her consent for being nominated.

Heikki Mäkijärvi (b. 1959, Master of Science, Technology) has enjoyed a long career in international management positions in the telecommunications sector. In his career, he has specialised in business development and start-up investments in particular. He has for example worked for Deutsche Telekom, Accel Partners and Cisco. Heikki Mäkijärvi is independent from DNA Plc and its largest shareholders.

Further information about other proposed board members is available on the DNA website at www.dna.fi/board-of-directors.

The Nomination Committee also proposes that Pertti Korhonen continues as the Chairman of the Board of Directors.

Remuneration of the Board of Directors

The Shareholders' Nomination Committee proposes that the remuneration of the Board of Directors remain unchanged. The Nomination Committee proposes that the Chairman of the Board be paid annual remuneration of EUR 144,000 and the members EUR 48,000. The Nomination Committee also proposes that the Board be paid a meeting fee of EUR 1,050 per meeting. The fee for each Chairman of a permanent Committee is EUR 1,050 per meeting, and for each committee member, EUR 525 per meeting.

The Nomination Committee recommends that each member of the Board annually spend 40% of their annual remuneration, net of withholding tax, for the purchase of the company's shares until the value of their shareholding corresponds to the gross amount of the annual remuneration. The shares are purchased half-yearly on the stock market. All share purchase costs are paid by the company.

The decisions and guidelines of the tax administration apply to the remuneration of travel expenses. 

Shareholders' Nomination Committee

The Nomination Committee consists of three members appointed by the shareholders. The members of the Nomination Committee are Esa Haavisto (Chairman, appointed by Finda Oy), Seppo Vikström (appointed by PHP Holding Oy) and Esko Torstila (appointed by Ilmarinen Mutual Pension Insurance Company). In addition, the Chairman of the company's Board of Directors participates in committee work in the capacity of a specialist.

The three shareholders entered in the company's shareholders' register maintained by Euroclear Finland Ltd, whose portion of the votes produced by all the shares in the company according to the shareholders' register are the greatest on 1 September each year, shall have the right to appoint members representing shareholders.

Further information:

Esa Haavisto, Chairman of the Nomination Committee, tel. +358 50 059 1877

Appendice:
Picture of Heikki Mäkijärvi 

Distribution:
Nasdaq Helsinki
Key media
www.dna.fi

DNA Plc is a Finnish telecommunications group providing high-quality voice, data and TV services for communication, entertainment and working. DNA is Finland's largest cable operator and the leading pay TV provider in both cable and terrestrial networks. For DNA, the key area for growth in corporate business is the new way of working, independent of time and place, facilitated by smart terminal devices, diverse communications services and rapid connections. In 2016, DNA recorded net sales of EUR 859 million and an operating profit of EUR 91 million. DNA has more than 3.8 million subscriptions in its fixed and mobile communications networks. The Group also includes DNA Store, Finland's largest retail chain selling mobile phones. DNA shares are listed on Nasdaq Helsinki Ltd. For further information, visit www.dna.fi or follow us on Twitter @DNA_fi, @DNA_Business and @DNA_Palvelu and Facebook.

Heikki Mäkijärvi



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DNA Oyj via Globenewswire

Per maggiori informazioni
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Slide ShowSlide Show
Non disponibili